Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumors for Phase Ib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06431243
What this trial is testing

A Clinical Study of Purinostat Mesylate for Injection in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Chengdu Zenitar Biomedical Technology Co., Ltd 132
Testing effectiveness (Phase 2)Study completedNCT00070252
What this trial is testing

Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer

Who this might be right for
Adult Solid NeoplasmInflammatory Breast CarcinomaMale Breast Carcinoma+2 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07170787
What this trial is testing

IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 104
Early research (Phase 1)Looking for participantsNCT07381829
What this trial is testing

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer

Who this might be right for
Advanced Solid Tumor Cancer
HC Biopharma Inc. 328
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)UnknownNCT06078670
What this trial is testing

PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Fujian Cancer Hospital 96
Testing effectiveness (Phase 2)Looking for participantsNCT06474455
What this trial is testing

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd. 156
Early research (Phase 1)Looking for participantsNCT05857332
What this trial is testing

SG1906 for CLDN18.2-Positive Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors
Hangzhou Sumgen Biotech Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT03206021
What this trial is testing

COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid Tumors

Who this might be right for
Recurrent Childhood CNS TumorEpendymoma, Recurrent ChildhoodChildhood Solid Tumor
The Hospital for Sick Children 31
Early research (Phase 1)Study completedNCT01209143
What this trial is testing

Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Who this might be right for
Solid Cancers
Genentech, Inc. 52
Testing effectiveness (Phase 2)Looking for participantsNCT06703177
What this trial is testing

SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors

Who this might be right for
Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 876
Early research (Phase 1)Active Not RecruitingNCT04058756
What this trial is testing

Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 120
Early research (Phase 1)UnknownNCT01341834
What this trial is testing

Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors

Who this might be right for
Nasopharyngeal Carcinoma, Lymphomas, Any EBV+ Solid Tumour
National Cancer Centre, Singapore 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT05949619
What this trial is testing

BL-M02D1 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer or Other Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 14
Testing effectiveness (Phase 2)Looking for participantsNCT07594626
What this trial is testing

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

Who this might be right for
Metastatic Biliary Tract CarcinomaMetastatic Colon CarcinomaMetastatic Esophageal Carcinoma+5 more
Northwestern University 72
Testing effectiveness (Phase 2)Looking for participantsNCT05053971
What this trial is testing

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmLocally Advanced Pancreatic CarcinomaMetastatic Pancreatic Carcinoma+6 more
National Cancer Institute (NCI) 49
Early research (Phase 1)Ended earlyNCT00985374
What this trial is testing

A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Hoffmann-La Roche 11
Testing effectiveness (Phase 2)Temporarily pausedNCT04946864
What this trial is testing

Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer

Who this might be right for
Breast CancerSolid Tumor, Adult
Ascentage Pharma Group Inc. 65
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Next Page